Drugs Made In America Acquisition II Corp. Unit (DMIIU)
$10.20▼ −0.10%
Close Sep 25, 2026 · split-adjusted
Sep 25, 2026$10.20▲ 2.20% in range
Sep 29, 2025Low $9.95 · High $10.25Sep 25, 2026
What changed · written from our data
As of Sep 28, 2026
Drugs Made In America Acquisition II Corp. Unit closed at $10.20 on Sep 25, down 0.10%, within 2.6% of its lowest close since Sep 25. Volume of 100 shares was 0.05× its 20-day average (below normal).
Split-adjusted performance: +1.6% over six months.
Short interest was 1.2K shares at the Sep 15 settlement, down 23.2% from the prior report (131.7 days to cover).
No recent articles focused on Drugs Made In America Acquisition II Corp. Unit.
Quick answers
What does Drugs Made In America Acquisition II Corp. Unit do?
Drugs Made In America Acquisition II Corp is a blank check Company.
What sector is DMIIU in?
Financials, in the Blank Checks industry.
About Drugs Made In America Acquisition II Corp. Unit
Drugs Made In America Acquisition II Corp is a blank check Company.
HQ: New York, NY2 employeesListed Sep 25, 2025
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology